4//SEC Filing
Kamal Fariborz 4
Accession 0001567619-22-002465
CIK 0001650648other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:39 PM ET
Size
5.7 KB
Accession
0001567619-22-002465
Insider Transaction Report
Form 4
Kamal Fariborz
President & COO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+70,000→ 70,000 totalExercise: $15.78Exp: 2032-01-31→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.
Documents
Issuer
4D Molecular Therapeutics Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001834020
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:39 PM ET
- Size
- 5.7 KB